Canada · Delayed Price · Currency is CAD Nanalysis Scientific Earnings Call Transcripts
Fiscal Year 2025
-
Q4 2025 revenue declined 13% year-over-year to CAD 10.7 million, mainly due to lower Scientific Equipment sales and the exit from third-party resale businesses. Gross margins and adjusted EBITDA also decreased, but operational improvements, new funding, and a focus on proprietary products position the company for improved profitability.
-
Q3 2025 revenue declined 12% year-over-year due to discontinued business lines and global demand softness, while security services revenue grew 10%. Gross margins fell in product sales but improved in security services, and supply chain issues were resolved.
-
Second quarter results were disappointing due to economic uncertainty and delayed customer orders, but sequential gross margin improvements were achieved, especially in services. Confidence remains high for a strong second half as supply chain risks are addressed.
-
Q2 2025 revenue fell 16.5% year-over-year due to lower product sales, but gross margins improved to 61%. Security Services revenue grew 9.9%, and management expects margin gains and delayed sales to materialize in the second half of 2025.
-
Q1 2025 saw revenue decline 5% year-over-year but gross margin and adjusted EBITDA improved, with net loss narrowing by CAD 1.2 million. Management remains confident in the 2025 outlook, citing strong sales funnel and positive operating cash flow.
Fiscal Year 2024
-
Positive gross margins and operational efficiency were achieved, with normalized Q4 net loss at CAD 400,000 and strong cash flow. A CAD 7 million impairment was recorded, but future growth and margin expansion remain priorities.
-
Revenue grew 60% year-over-year in 2024, with strong margin and EBITDA improvements driven by operational efficiencies and service segment growth. Focus remains on proprietary products, margin expansion, and mitigating macro risks, with positive momentum expected into 2025.
-
Revenue grew 50% year-over-year to CAD 10.6M, with improved gross margins and two straight quarters of positive EBITDA. Q3 was seasonally slow, but Q4 is expected to be strong, supported by sales rollover and new product focus.
-
Q3 2024 saw 50% revenue growth, margin improvements, and positive adjusted EBITDA, driven by strong product and service performance. Outlook for Q4 is robust, with deferred orders and new product launches expected to fuel further growth.
-
A patented thermal battery solution addresses rising energy costs, grid limitations, and carbon taxes by efficiently storing electricity as heat for residential heating. Commercialization is targeted for 2025, with a $1M funding round underway and a U.S. patent expected early next year.
-
Record Q2 revenue and positive EBITDA were driven by strong product and services growth, cost reductions, and margin improvements. Management expects continued momentum, new product launches, and further margin expansion in the second half of 2024.